GeoVax Labs, Inc. received a Nasdaq notice of non-compliance with the $2,500,000 minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1). The company has until August 21, 2026, to submit a plan to regain compliance, with the potential for a 180-day extension if the plan is accepted. GeoVax Labs, Inc. is a biotechnology company focused on developing vaccine and immunotherapy products.